{"name":"Biomay AG","slug":"biomay-ag","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"BM32","genericName":"BM32","slug":"bm32","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"BM32","genericName":"BM32","slug":"bm32","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxPVWlhZTF3WHcwOWE5dGxjak5uQXBDN3FGSm9SaXkxaG1NdjYxQllQUjFaYkRpMXYtLTdZaHc3Wlk5TV9WbTBxS3VxUjNUOFJ2bkNybDZEb0dTRC0xYzV3eE1nZk1QNV8zcXplU0VVNG85UzEyT3BzaExnajltQVVFd1FNX0Q2X2lCODlXSGhnY1JDcE0?oc=5","date":"2026-04-08","type":"pipeline","source":"openPR.com","summary":"Top Companies and Competitive Dynamics in the Allergy Immunotherapy Market - openPR.com","headline":"Top Companies and Competitive Dynamics in the Allergy Immunotherapy Market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxOS19lLWh3S1JoT1hlX05VVTdVRGxNTllIQ0NFMlJMSG5MdWVGTGV3UXdBMVBWbHhPaVAyQ2cyb1VJVTN0OVU1RDM4bnVIbmtSazRJTDZxOW9GV2RwNHN1dTRyaGJ0aUxXcVR1NTJwc3o5RzRWZEhjRFpsWEhWOEpGZ004UHhmcTRlYm03TFVJb0RCZ2dicEFjbnVoOW85VXVUZHc?oc=5","date":"2025-11-19","type":"patent","source":"Bloomberg Law News","summary":"Vertex, Crispr’s Casgevy Accused of Infringing New ToolGen Patent - Bloomberg Law News","headline":"Vertex, Crispr’s Casgevy Accused of Infringing New ToolGen Patent","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxNVDdndnB4dXZWYm1COUVhUW1XR0JrVFlVT1BhM1lOcGpMbDV2eUJpVjhSeFJ5WlZXX1QxVG9PSGd1OEhCTkw4WVlGZzFqVW5WSE1OY2J4QlBRcW9RQ195S3p5X0xsXzg5LVRKTjhHSms0bUNsaDkwcEhVZE9veUYtN2FRa1lnS3YzSkFSN0VKMDlFQVg0SFJVaW53TktuQjc4YVBqU295UnhRLXRDR1BwQVA4MVh4V3FfNS02cUJDeC1SdlNCRENRZHFvYTY1QV9ybnpwUUhEaEE?oc=5","date":"2025-05-09","type":"regulatory","source":"sttinfo.fi","summary":"Biomay Launches FDA-Grade CRISPR/Cas9 Nuclease for Off-the-Shelf Purchase - sttinfo.fi","headline":"Biomay Launches FDA-Grade CRISPR/Cas9 Nuclease for Off-the-Shelf Purchase","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxNc3hCbXhfczFYMWpaYVB3TFlsNE4yeGNTMDhKUTlaR1BFNEdwTVBlaVhkMDNLWjRKOXdoN1RCY0x0SFlEaFBJbHJObUJLSFVyaE9LTnJ3QTNHaW42SXU5am15UTUwMjdRdmRaOVdIbmhyU3Nyc3RvS2stcWtaSkxHZnRERklCTmxNZ3Y4clFkOUdXUQ?oc=5","date":"2025-02-10","type":"pipeline","source":"Future Market Insights","summary":"Allergy Immunotherapy Market Trends & Competitive Outlook - Future Market Insights","headline":"Allergy Immunotherapy Market Trends & Competitive Outlook","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9AFBVV95cUxPSklBSUQxeEotX3NPM1JESEg4Skh6U1BHUGFsVzFlUU9xbFM2LTRjc2ZPb1IxZmpHdGNPTzlyb3dra1dLUGgzcVNYc1VNcWZjSnlnb1JnYnZsbXFoVDdzVXI2VWJUOW1iVVp0Z3p5dUY4Q2hYeWROd2NwZzJQbk9Cdmw0OFN5MEVUcUNNbHI5VlVJNTMzeWRUYlVZU1JLRzBLWUlVNGMwWGZfR0R5NFV5bklwd0hNZHpuaTNFMm03blQzSWdwTTJqVm9xZG9SOWNqaFNGd05BVjNTUGJrckhWUGFNcmpIc0Y5dTdDRk5BZi1RNWti?oc=5","date":"2024-01-26","type":"regulatory","source":"Via Ritzau","summary":"Biomay Announces its Successful Support of Approval of First CRISPR/Cas9-based Therapy - Via Ritzau","headline":"Biomay Announces its Successful Support of Approval of First CRISPR/Cas9-based Therapy","sentiment":"positive"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}